The hype about GLP-1 drugs for Type 2 diabetes and/or obesity reached new heights as TIME dipped into the abyss of obsequiousness with its recent cover story about drugmaker Eli Lilly and research on a new oral pill to compete with the current injectable products.
Wow! Time’s hype is off the charts. I hope Lilly is successful, but there’s hard science yet to come and it will likely be thoroughly scrutinized. So many drugs over the years have been badly hyped at the expense of the public’s health. There are always side effects, it seems, once they get to market. Lesson: no magic panaceas!
Wow! Time’s hype is off the charts. I hope Lilly is successful, but there’s hard science yet to come and it will likely be thoroughly scrutinized. So many drugs over the years have been badly hyped at the expense of the public’s health. There are always side effects, it seems, once they get to market. Lesson: no magic panaceas!